Integra LifeSciences Holdings Corporation
DE ˙ DB ˙ US4579852082
14,80 € ↑1,10 (8,03%)
2026-06-05
DEL PRIS
SecurityDE:IL3 / Integra LifeSciences Holdings Corporation
InstitutionRsm Us Wealth Management Llc
Latest Disclosed Ownership30,856 shares
Latest Disclosed Value $ 290,664
Rsm Us Wealth Management Llc reports 11.95% increase in ownership of IL3 / Integra LifeSciences Holdings Corporation

On May 12, 2026 - Rsm Us Wealth Management Llc filed a 13F-HR form disclosing ownership of 30,856 shares of Integra LifeSciences Holdings Corporation (DE:IL3) valued at $243,762 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 23, 2026 disclosing 27,562 shares of Integra LifeSciences Holdings Corporation. This represents a change in shares of 11.95% during the quarter. The current value of the position is $456,669 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 30,856 3,294 11.95 291 -16.91 0.0036
2026-01-23 2025-12-31 13F INTEGRA LIFESCIENCES HLDGS COM NEW 457985208 27,562 -2,299 -7.70 349 -18.27 0.0045
2025-11-12 2025-09-30 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 29,861 29,861 428 0.0056
2025-08-13 2025-06-30 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 0 -21,654 -100.00 0 -100.00
2025-05-06 2025-03-31 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 21,654 -620 -2.78 476 -4.80 0.0074
2025-01-27 2024-12-31 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 22,274 5,123 29.87 500 66.67 0.0072
2024-11-07 2024-09-30 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 17,151 5,536 47.66 300 -10.71 0.0044
2024-08-07 2024-06-30 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 11,615 11,615 336 0.0056
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.